Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

loner4799 69 posts  |  Last Activity: Apr 14, 2015 10:15 AM Member since: Jan 28, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • but the big money just got leaked to. Probably the phase 2 announcement, it was a 4 bagger on phase one, BEFORE they injected a soul, so the easy guess is $ 30.00 + dollars just on the announcement. If they release the other 20 patients from phase one, and the same results add another 10 to $ 15.00 dollars to the price. If the Ema grants early commercialization, add another $ 10.00 dollars. If there is a partnership announcements all bets are off!

  • Phase one pre split went from 6 cents to 27 cents. post split has many characteristics that are VERY different. Would the price at a bare minimum go to $ 30.00 dollars. There are only 34 million o/s shares, there are no more legal, and internal ( gary rabin issues ) they have cured the blind, and 100 % stopped the disease, they are on the nasdaq, and I could go on. Some in my investment group, and we own a ton of shares, believe the stock will easily outperform the announcement of phase 1 ie. $ 65.00 dollars easy.what say you'all

  • Reply to

    phase2, hm I have some thoughts

    by loner4799 Apr 12, 2015 5:29 PM
    loner4799 loner4799 Apr 12, 2015 8:57 PM Flag

    really if phase 2 is on it's way they are in a serious SEC violation phase, that is a MAJOR event and they LEGALLY are required to report to shareholders in a 48 hour period. So that is clearly a lie

  • will start in a year, and they will be silent about it as usual, it will be wrapped in a shroud, delays and missed deadlines, en mass, all the while self dealing more and more shares, and if there is a pump on the price the insiders sell EVERYTIME. NOt one insider has reached into their own pocket to spend a dime on shares. and notice, they can never ever ever ever find a psrtner gee I wonder why???

  • loner4799 loner4799 Apr 12, 2015 5:25 PM Flag

    I agree that is the sole reason NO ONE after YEARS of searching will partner with them , here comes the dilution, dilution , dilution, and more raises and bonuses. Fleecing the shareholders for years. This rifling of the company , coming soon will start the runs to $ 2.00 dollars or lower, watch her drown

  • who were the suckers, raise your hand that bought at $ 4.86 ,tee hhheee hhheeeee, what a bunch of idiots get out before you lose everything. I remember the good old day, tee hee hhe oh lemons and baggies, grab yer ankles shes about to tank again

  • and dilute all 100 million, that's approx 600 million dollars , everyone would be so happy, they could finish all the way to phase 3, and launch all the other projects in waiting, and only have 135 million shares os. SO BIG DEAL TEVA , a monster in the industry has 950 million o/s shares, and their price is fantastic. These guys have cured the blind the price pps would even be higher I really don't know why they are sweating it , they can always split forward after the halt in the middle of phase 2 in Europe

  • loner4799 loner4799 Apr 7, 2015 11:59 AM Flag

    there has only been about $ 800,000.00 thousand in trading today , really not that much

  • they are getting ready to release the other 20 patients from phase one, that just finished. This was the catalyst that PW left a 2 million dollara year job for, , instead he now only gets 300 g. or maybe it's the phase 2 data from CHA they are done by now , and about to go to market or start phase three. or this chinese 4 person data. Or maybe it's just the start of our phase 2, bear in mind when we started phas eone pre split the price went from 6 cents to 27 cents, so imagine a green light for phase 2, probably 25 dollars easy

  • best thing that ever happened to this co. They got so scared they lied, for example, they said pay full price , I never suggested that, I said at a discount, we are trading at $ 6.57 , so 6 would be a deal, especially when they announce the other 20 patients , and the start of phase 2, automatically back to 13 dollars. Never believe a basher. Then the next lie was oCATA never cured the blind, that is another blatent lie, besides the famous cowboy that went from 400/20 to 40/20 in 2 weeks, the pub owner in the UK, and on and on. More than that they don't even need to cure just stop the disease to be a trillion dollar company. Yes the paid bashers are deathly afraid of the dilution. It would solve all of Ocata's problems. Well we can just watch the paid bashers try to lie there way out of the upcoming results, and the new trials, should be fun to watch, get your popcorn. I always thought on a huge company as this one is about to be, that the higher paid bashers/liars were hired, these bashers are very lightweight. I've seen better, by far.

  • and dilute all 100 million, that's approx 600 million dollars , everyone would be so happy, they could finish all the way to phase 3, and launch all the other projects in waiting, and only have 135 million shares os. SO BIG DEAL TEVA , a monster in the industry has 950 million o/s shares, and their price is fantastic. These guys have cured the blind the price pps would even be higher I really don't know why they are sweating it , they can always split forward after the halt in the middle of phase 2 in Europe.

  • loner4799 by loner4799 Mar 31, 2015 7:11 PM Flag

    sell lincoln, 100 million shares and get 600 million to work with. 135 million o/s shares is nothing. Teva has 950 million o/s shares. So big deal. They have the cure to blindness, so the trillions that they would make would be worth it. They can always forward split. Having 600 million, gets them through phase 3 and starts all IND's and the pipeline of trials. What's the hold up.

  • loner4799 loner4799 Mar 25, 2015 5:06 PM Flag

    That was spot on, and only the smart will get it. they now have all the bases covered. So if you want to play in out sand box it will cost you, embryonic or otherwise!! Well put
    AND look at these conservative # ,s
    The numbers are staggering in case you didn't know.

    There will be 200 million people with AMD globally by 2020, increasing to nearly 300 million by 2040. FACTS

    If you only treat 10 % of the population, 200 million in 2020, that's 20 million patients, at a cost of $ 100,000.00 per treatment, that would be ( put on your thinking cap )
    $ 200 TRILLION DOLLARS , the cost per vial is $ 100.00 dollars, plus expenses, even if you put total overhead at say 35 % , that is still approx. 70 TRILLION in profit. Then you would have to factor in The P/E ( price per earnings formula )
    oh say a p/e ratio of 15, very conservative, you get about $ 3,020.00 dollars per share, and that is ONLY A 10 % market penetration!

  • so we get our 600 million, and

    loner4799 • 1 hour 20 minutes ago Remove

    1 users liked this posts users disliked this posts 3
    Reply

    for those that are math challenged here are the numbers for you, and this assumes only a 10 % market penetration

    follow the real info and the math
    The numbers are staggering in case you didn't know.

    There will be 200 million people with AMD globally by 2020, increasing to nearly 300 million by 2040. FACTS

    If you only treat 10 % of the population, 200 million in 2020, that's 20 million patients, at a cost of $ 100,000.00 per treatment, that would be ( put on your thinking cap )
    $ 200 TRILLION DOLLARS , the cost per vial is $ 100.00 dollars, plus expenses, even if you put total overhead at say 35 % , that is still approx. 70 TRILLION in profit. Then you would have to factor in The P/E ( price per earnings formula )
    oh say a p/e ratio of 15, very conservative, you get about $ 3,020.00 dollars per share, and that is ONLY A 10 % market penetration! Less

  • loner4799 loner4799 Mar 24, 2015 4:58 PM Flag

    we pulled the offering

  • loner4799 loner4799 Mar 24, 2015 4:56 PM Flag

    if we get all 50 million now, ( the next year to two ) well you would need a scientific calculator, in the quadrillions. Not so unlikely I don't see a competitor even 5 years behind us, and as we all know Ocata has orphan drug status, so a 7 year exclusive no matter what. It's a no brainer. I for one am going to load up as much as I can before they get approval which will be Europe first and only ( my bet ) 6 months form the first injection of phase two which will start in a month or less. Good luck gentlemen!

  • follow the real info and the math
    The numbers are staggering in case you didn't know.

    There will be 200 million people with AMD globally by 2020, increasing to nearly 300 million by 2040. FACTS

    If you only treat 10 % of the population, 200 million in 2020, that's 20 million patients, at a cost of $ 100,000.00 per treatment, that would be ( put on your thinking cap )
    $ 200 TRILLION DOLLARS , the cost per vial is $ 100.00 dollars, plus expenses, even if you put total overhead at say 35 % , that is still approx. 70 TRILLION in profit. Then you would have to factor in The P/E ( price per earnings formula )
    oh say a p/e ratio of 15, very conservative, you get about $ 3,020.00 dollars per share, and that is ONLY A 10 % market penetration!

  • loner4799 loner4799 Mar 24, 2015 4:17 PM Flag

    Moreover even if it stays at $ 6.00 dollars that dilution would yield $ 600 MILLION DOLLARS it's enough to start all of their ind's. I just wish they would do it and get it over with. The reality is they will use Lincoln, BUT after the announcement of phase 2, the 4 chinese patients, and the phase 2 from the Cha patients. That should be enough to put the pps to $ 26.00 or more, and if that isn't enough then they release the hold card, the other phase one patients, THE ONES THAT MADE PW LEAVE A 2 MILLION DOLLAR JOB , for a measly
    300 k. Then maybe they only have to dilute up to 100 million. I just wish they would do it and really start all the trials in all the categories. The price will be in the hundreds real fast. No debt , no more lawsuits , no more bad management. Either way, if they get a partner or two from non core product or just dilute , it won't be long 2 years is nothing to be the largest company in the world. For those that don't know there are ( without factoring in the ever increasing population ) approx 50 million people worldwide, TIMES $ 100,000.00 dollars ; ok kiddies beak out your scientific calculators.

  • It will never get to the end of phase 2 , at best 25 % of phase 2 and it will be halted, certainly in Europe, if not the Fda also. I would prefer they use Lincoln, we only have 34 million outstanding, shares. Teva, for example has almost a billion o/s shares, at the most we will only need to dilute another 100 million, big deal, 134 million shares. Your talking about ( as stated by Rabin verbatim ) $ 100,000.00 dollars per injection. If you know the numbers worldwide that need to be treated, then you know that with the ONE eye disease this company will be bigger than Apple. Do your own research on how many victims of this disease there is, and multiply that by $ 100,000.00 dollars and get back to me. Bear in mind Lanza is on record, also verbatim, " the cost of a vial for the syringe shot is $ 100.00 dollars , the mark up is off the chart. According to PW the price has already eagerly, might I add, by the insurance companies, as opposed to taking care of a blind person the ret of their life. And finally it's NOT A VACCINATION, it's just a cure or reversal of blindness, so it is a never ending supply of patients. It's all about just relaxing and waiting another year or two. Not to mention all the other 199 other eye diseases!, Eternal blood supply, animal treatments, and the MSC's , I hope they don't give the co away for a few billion, just keep using Lincoln, everyone will still be filthy rich even with 200 million 0/s shares

ACTC
6.97+0.17(+2.50%)Nov 13 3:59 PMEST